Addus HomeCare Co. (NASDAQ:ADUS) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) have earned an average recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $131.38.

A number of research firms have commented on ADUS. TD Cowen lifted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a report on Thursday, August 8th. Stephens reaffirmed an "overweight" rating and set a $138.00 target price on shares of Addus HomeCare in a report on Tuesday, August 6th. KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 target price for the company. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. Finally, Macquarie reissued an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Friday, October 11th.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of the business's stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now directly owns 3,866 shares in the company, valued at $502,695.98. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Esteban Lopez sold 500 shares of the business's stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now directly owns 3,866 shares in the company, valued at $502,695.98. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock valued at $3,050,082 in the last three months. 4.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Asset Management L.P. grew its position in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock worth $86,598,000 after purchasing an additional 315,602 shares in the last quarter. Millennium Management LLC grew its position in shares of Addus HomeCare by 412.7% during the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company's stock worth $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Boston Partners acquired a new position in shares of Addus HomeCare during the 1st quarter worth approximately $12,215,000. Ghisallo Capital Management LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $11,611,000. Finally, Lord Abbett & CO. LLC acquired a new position in shares of Addus HomeCare during the 1st quarter worth approximately $8,274,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Stock Down 0.9 %

ADUS traded down $1.20 during midday trading on Friday, reaching $131.81. 85,349 shares of the company's stock were exchanged, compared to its average volume of 131,540. Addus HomeCare has a one year low of $78.35 and a one year high of $136.12. The business has a 50-day simple moving average of $130.33 and a two-hundred day simple moving average of $117.94. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of 33.00, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to analysts' expectations of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. Addus HomeCare's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.94 earnings per share. As a group, research analysts anticipate that Addus HomeCare will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.